exciting times for hormone-sensitive prostate cancer treatment
Published 1 year ago • 129 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:17
treatment landscape for metastatic hormone-sensitive prostate cancer
-
0:47
systemic triple therapy in metastatic hormone-sensitive prostate cancer
-
1:56
arasens: dialuramide plus adt and docetaxel for metastatic hormone-sensitive prostate cancer
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
3:20
radiation therapy for the local treatment of metastatic hormone-sensitive prostate cancer
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
18:06
how the aranote trial results could advance prostate cancer treatment
-
3:44
the evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
-
4:05
evaluating triplet therapy in metastatic hormone sensitive prostate cancer
-
13:09
pca commentary: metastatic hormone sensitive prostate cancer (mhspc): many treatment options
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
4:52
understanding metastatic hormone-sensitive prostate cancer (mhspc) with dr. fred saad
-
1:24
dr. higano on docetaxel for hormone-sensitive prostate cancer
-
3:51
metastatic hormone-sensitive prostate cancer (mhspc)
-
44:49
'treatment landscape for metastatic hormone-sensitive prostate cancer' - dr laeeq malik grand rounds
-
2:27
triplet therapy for metastatic hormone-sensitive prostate cancer
-
5:39
early treatment intensification for mcspc: optimising patient selection and treatment
-
49:02
treatment for hormone sensitive prostate cancer